Relmada Therapeutics (RLMD) Asset Utilization Ratio (2013 - 2023)
Relmada Therapeutics' (RLMD) Asset Utilization Ratio stood at 0.04 in Q4 2023, up 255.8% from 0.01 a year earlier and up 16.5% from the prior quarter.
Powered by 
Analysis
Relmada Therapeutics (RLMD) Asset Utilization Ratio (2013 - 2023) Analysis & Trends
Starting with Q3 2013, Relmada Therapeutics' Asset Utilization Ratio history includes 19 quarters.
- Across earlier years, Asset Utilization Ratio came in at 0.01 in FY2022 (+234.3%), 0.00 in FY2021, -1.24 in FY2020 and -0.07 in FY2019.
- The Q4 2023 figure is the highest quarterly Asset Utilization Ratio since Q4 2013.
- On a year-over-year basis, Asset Utilization Ratio has increased for three consecutive quarters.
- Per Business Quant, the preceding three quarters came in at 0.04 (Q3 2023), 0.03 (Q2 2023) and 0.02 (Q1 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 0.60 |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 0.50 |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 0.47 |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 0.51 |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 0.45 |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 0.47 |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 0.41 |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 0.62 |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 0.31 |
| 10 | Relmada Therapeutics | 473.10 Mn | -85.48 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 0.04 |
| Sep 30, 2023 | 0.04 |
| Jun 30, 2023 | 0.03 |
| Mar 31, 2023 | 0.02 |
| Dec 31, 2022 | 0.01 |
| Sep 30, 2022 | 0.01 |
| Jun 30, 2022 | 0.00 |
| Mar 31, 2022 | -0.13 |
| Dec 31, 2021 | -0.42 |
| Sep 30, 2021 | -0.65 |
| Jun 30, 2021 | -0.61 |
| Mar 31, 2021 | -0.39 |
| Dec 31, 2020 | -0.17 |
| Sep 30, 2020 | -0.16 |
| Jun 30, 2020 | -0.17 |
| Mar 31, 2020 | -0.11 |
| Dec 31, 2019 | 0.01 |
| Sep 30, 2019 | -0.08 |
| Mar 31, 2019 | -0.48 |
| Dec 31, 2018 | -0.75 |
API Access
Relmada Therapeutics Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=RLMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "RLMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=RLMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();